Awareness, predictors and outcomes of drug alerts among people who access harm reduction services in British Columbia, Canada: findings from a 2021 cross-sectional survey.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
09 05 2023
Historique:
medline: 11 5 2023
pubmed: 10 5 2023
entrez: 9 5 2023
Statut: epublish

Résumé

To assess the awareness and predictors of seeing/hearing a drug alert in British Columbia (BC) and subsequent drug use behaviour after seeing/hearing an alert. This study analysed the 2021 BC harm reduction client survey (HRCS)-a cross-sectional self-reported survey administered at harm reduction sites throughout the province and completed by participants using the services. In total, n=537 respondents participated and n=482 (89.8%) responded to the question asking if they saw/heard a drug alert. Of those, n=300 (62.2%) stated that they saw/heard a drug alert and almost half reported hearing from a friend or peer network; the majority (67.4%) reported altering their drug use behaviour to be safer after seeing/hearing a drug alert. The proportion of individuals who saw/heard a drug alert increased with each ascending age category. Among health authorities, there were significant differences in the odds of seeing/hearing an alert. In the past 6 months, the odds of participants who attended harm reduction sites a few times per month seeing/hearing an alert were 2.73 (95% CI: 1.17 to 6.52) times the odds of those who did not. Those who attended more frequently were less likely to report seeing/hearing a drug alert. The odds of those who witnessed an opioid-related overdose in the past 6 months seeing/hearing an alert were 1.96 (95% CI: 0.86 to 4.50) times the odds of those who had not. We found that drug alerts were mostly disseminated through communication with friends or peers and that most participants altered their drug use behaviour after seeing/hearing a drug alert. Therefore, drug alerts can play a role in reducing harms from substance use and more work is needed to reach diverse populations, such as younger people, those in differing geographical locations, and those who attend harm reduction sites more frequently.

Identifiants

pubmed: 37160395
pii: bmjopen-2022-071379
doi: 10.1136/bmjopen-2022-071379
pmc: PMC10174008
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e071379

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Subst Abuse Treat. 2021 Jun;125:108313
pubmed: 34016300
CMAJ Open. 2015 Jan 13;3(1):E83-90
pubmed: 25844375
Harm Reduct J. 2014 Apr 27;11:13
pubmed: 24766846
Int J Drug Policy. 2022 Jul;105:103714
pubmed: 35561485
Addiction. 2013 Jul;108(7):1270-6
pubmed: 23551565
Drug Alcohol Depend. 2016 Feb 1;159:234-9
pubmed: 26754425
Public Health Rep. 2019 Jul/Aug;134(4):423-431
pubmed: 31211644
Int J Drug Policy. 2015 Dec;26(12):1251-7
pubmed: 26205676
Am J Drug Alcohol Abuse. 2020 Jul 3;46(4):506-511
pubmed: 31983241
Drug Alcohol Depend. 2019 May 1;198:1-6
pubmed: 30856370
Addiction. 2021 Jun;116(6):1495-1504
pubmed: 33119196
Drug Test Anal. 2014 Jul-Aug;6(7-8):819-24
pubmed: 24470121
Soc Sci Med. 2021 Feb;270:113631
pubmed: 33418149

Auteurs

Kerolos Daowd (K)

Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.

Max Ferguson (M)

Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada.

Lisa Liu (L)

Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada.

Jackson Loyal (J)

Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.

Kurt Lock (K)

Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada.

Brittany Graham (B)

Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada.

Jessica Lamb (J)

Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada.

Jenny McDougall (J)

Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada.

Jane A Buxton (JA)

Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada jane.buxton@ubc.ca.
School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH